The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology.

ZEISS and SERI will also work to develop more personalised solutions and improve surgical processes for faster visual rehabilitation and better long-term stability.

As of 8:00:02 am GMT+1. Market open. Carl Zeiss Meditec ( ETR:AFX ) Full Year 2024 Results Key Financial Results Revenue: €2.07b (down 1.1% from FY 2023... There are a few key trends to look for if we ...

Zeiss South Africa’s MD, Seyfi Ceyhan, travels far and wide for work but cherishes every moment with his family during limited downtime.